The trademark application ELADYNOS TD was filed by Radius Health, Inc., a U.S. corporation (the "Applicant"). The application was published for oppositions on March 7, 2022, and it was registered by office on June 14, 2022 without any oppositions.
The application was filed in English (French was selected as the second language).
Goods And Services
The mark was filed in class 5 with following description of goods:
Pharmaceutical preparations for use in the treatment of bone diseases
Pharmaceutical preparations for use in the treatment of connective tissue diseases, inflammatory diseases, blood diseases and hormonal disorders
Pharmaceutical preparations for use in the treatment of wasting and other muscle, fat and tissue loss caused by medical disorders or aging
Pharmaceutical preparations for use in hormone therapy
Pharmaceutical preparations for use in the treatment of cardiovascular diseases, central and peripheral nervous system diseases, cancer, gynecological diseases, rheumatic diseases, urological diseases, gastroenterological diseases, infectious diseases, dermatological diseases, autoimmune diseases, blood diseases, genital diseases, endocrine diseases, intestinal diseases, internal medicine diseases
Pharmaceutical preparations for use in the treatment of alopecia
Pharmaceutical preparations for use in the treatment of cognitive disorders and mood disorders
Pharmaceutical preparations for use in the treatment of diabetes and insulin-related disorders and conditions
Pharmaceutical preparations to treat wounds and trauma.